Cysteamine

Cysteamine

SCHEMBL1010057

NCCS.NCCS.O=C(O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Cysteamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
CYP3A4 P08684 1/20 0.61
LMNA P02545 3/20 0.57
BLM P54132 3/20 0.57
ALDH1A1 P00352 2/20 0.57
MAPT P10636 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
GLRA1 P23415 1/20 0.44
SLC6A9 P48067 1/20 0.44
OR51E2 Q9H255 1/20 0.44
GABRR1 P24046 3/20 0.40
CPB2 Q96IY4 2/20 0.40
THRB P10828 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
GABRR3 A8MPY1 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
HDAC3 O15379 1/20 0.40
GABBR2 O75899 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteamine SCHEMBL5502656 1.00
Carbamic Acid SCHEMBL27915357 0.89
Acetic Acid SCHEMBL4032886 0.86
Thioglycolic Acid SCHEMBL7083512 0.86
Glycine SCHEMBL28461223 0.86
Urea SCHEMBL28501633 0.85
Succinic Acid SCHEMBL28990895 0.83 ACE (0.57) TSHRCYP3A4LMNABLMALDH1A1
Acetic Acid SCHEMBL21826809 0.83
Urea SCHEMBL28460805 0.81
Beta-Alanine SCHEMBL17001487 0.81 LMNA (0.52) TSHRCYP3A4LMNABLMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478406-B1 COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND OTHER MATERIALS, AND METHODS OF MAKING AND USING THE SAME PHARMAIN CORP (US) 2011-01-05 EP claimed